152 related articles for article (PubMed ID: 30002362)
61. The Impact of Deceased Donor Liver Extraction Time on Early Allograft Function in Adult Liver Transplant Recipients.
Adelmann D; Roll GR; Kothari R; Syed S; Burdine LJ; Tavakol M; Niemann CU
Transplantation; 2018 Nov; 102(11):e466-e471. PubMed ID: 30048397
[TBL] [Abstract][Full Text] [Related]
62. Decreased Serum Levels of High Mobility Group Box 1 (HMGB-1) after Graft Replacement or Stenting of Abdominal Aortic Aneurysm.
Ousaka D; Fujii Y; Oozawa S; Nishibori M; Kuroko Y; Masuda Z; Sano S
Ann Vasc Surg; 2017 May; 41():265-270. PubMed ID: 27908811
[TBL] [Abstract][Full Text] [Related]
63. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
[TBL] [Abstract][Full Text] [Related]
64. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.
Ito T; Naini BV; Markovic D; Aziz A; Younan S; Lu M; Hirao H; Kadono K; Kojima H; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Am J Transplant; 2021 Feb; 21(2):614-625. PubMed ID: 32713098
[TBL] [Abstract][Full Text] [Related]
65. Neutrophil-to-lymphocyte ratio is a predictor of early graft dysfunction following living donor liver transplantation.
Kwon HM; Moon YJ; Jung KW; Park YS; Jun IG; Kim SO; Song JG; Hwang GS
Liver Int; 2019 Aug; 39(8):1545-1556. PubMed ID: 30903725
[TBL] [Abstract][Full Text] [Related]
66. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
[TBL] [Abstract][Full Text] [Related]
67. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis.
Hamada T; Torikai M; Kuwazuru A; Tanaka M; Horai N; Fukuda T; Yamada S; Nagayama S; Hashiguchi K; Sunahara N; Fukuzaki K; Nagata R; Komiya S; Maruyama I; Fukuda T; Abeyama K
Arthritis Rheum; 2008 Sep; 58(9):2675-85. PubMed ID: 18759291
[TBL] [Abstract][Full Text] [Related]
68. Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
Mazilescu LI; Kotha S; Ghanekar A; Lilly L; Reichman TW; Galvin Z; Cattral MS; Bhat M; McGilvray ID; Sapisochin G; Sayed B; Selzner M; Selzner N
Transplant Direct; 2021 Aug; 7(8):e727. PubMed ID: 34291149
[TBL] [Abstract][Full Text] [Related]
69. Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?
Andert A; Becker N; Ulmer F; Schöning W; Hein M; Rimek A; Neumann U; Schmeding M
Ann Transplant; 2016 Mar; 21():185-93. PubMed ID: 27029495
[TBL] [Abstract][Full Text] [Related]
70. Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant.
Avolio AW; Franco A; Schlegel A; Lai Q; Meli S; Burra P; Patrono D; Ravaioli M; Bassi D; Ferla F; Pagano D; Violi P; Camagni S; Dondossola D; Montalti R; Alrawashdeh W; Vitale A; Teofili L; Spoletini G; Magistri P; Bongini M; Rossi M; Mazzaferro V; Di Benedetto F; Hammond J; Vivarelli M; Agnes S; Colledan M; Carraro A; Cescon M; De Carlis L; Caccamo L; Gruttadauria S; Muiesan P; Cillo U; Romagnoli R; De Simone P
JAMA Surg; 2020 Dec; 155(12):e204095. PubMed ID: 33112390
[TBL] [Abstract][Full Text] [Related]
71. Pediatric Donor to Adult Recipients in Donation After Cardiac Death Liver Transplantation: A Single-Center Experience.
Lan C; Song JL; Yan LN; Yang JY; Wen TF; Li B; Xu MQ
Transplant Proc; 2017; 49(6):1383-1387. PubMed ID: 28736011
[TBL] [Abstract][Full Text] [Related]
72. Revascularization Time in Liver Transplantation: Independent Prediction of Inferior Short- and Long-term Outcomes by Prolonged Graft Implantation.
Buchholz BM; Gerlach UA; Chandrabalan VV; Hodson J; Gunson BK; Mergental H; Muiesan P; Isaac JR; Roberts KJ; Mirza DF; Perera MTPR
Transplantation; 2018 Dec; 102(12):2038-2055. PubMed ID: 29757901
[TBL] [Abstract][Full Text] [Related]
73. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.
Ueno T; Ikeda T; Ikeda K; Taniuchi H; Suda S; Yeung MY; Matsuno N
J Surg Res; 2011 Nov; 171(1):183-90. PubMed ID: 20338589
[TBL] [Abstract][Full Text] [Related]
74. [Efficacy of in-situ full-left/full-right split liver transplantation for adult recipients using the living donor liver transplantation technique:a single-center report of 25 cases].
Wu SD; Huang J; Fang JZ; Lu CJ; Wang GQ; Wang K; Ye S; Jiang W; Zhu HD; Hu YK; Mao SQ; Lu CD
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):906-914. PubMed ID: 36207979
[No Abstract] [Full Text] [Related]
75. Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.
Markmann JF; Abouljoud MS; Ghobrial RM; Bhati CS; Pelletier SJ; Lu AD; Ottmann S; Klair T; Eymard C; Roll GR; Magliocca J; Pruett TL; Reyes J; Black SM; Marsh CL; Schnickel G; Kinkhabwala M; Florman SS; Merani S; Demetris AJ; Kimura S; Rizzari M; Saharia A; Levy M; Agarwal A; Cigarroa FG; Eason JD; Syed S; Washburn WK; Parekh J; Moon J; Maskin A; Yeh H; Vagefi PA; MacConmara MP
JAMA Surg; 2022 Mar; 157(3):189-198. PubMed ID: 34985503
[TBL] [Abstract][Full Text] [Related]
76. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
77. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.
Deroose JP; Kazemier G; Zondervan P; Ijzermans JN; Metselaar HJ; Alwayn IP
HPB (Oxford); 2011 Jun; 13(6):417-25. PubMed ID: 21609375
[TBL] [Abstract][Full Text] [Related]
78. Risk Assessment in High- and Low-MELD Liver Transplantation.
Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
[TBL] [Abstract][Full Text] [Related]
79. Who fares worse after liver transplantation? Impact of donor and recipient variables on outcome: data from a prospective study.
Gambato M; Frigo AC; Rodríguez Castro KI; Senzolo M; Nadal E; D'Amico F; Vitale A; Gringeri E; Zanus G; Cillo U; Russo FP; Burra P
Transplantation; 2013 Jun; 95(12):1528-34. PubMed ID: 23722633
[TBL] [Abstract][Full Text] [Related]
80. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
Wagener G; Raffel B; Young AT; Minhaz M; Emond J
Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
